Kiniksa Pharmaceuticals International, plc (KNSA) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-03-31..
Quick ratio
Overview →Financial period ending 2026-03-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-03-31. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Debt Securities, Available-for-sale, Current · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 156.61M USD | Liabilities, Current |
| Cash and equivalents | 189.95M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | Debt Securities, Available-for-sale, Current |
| Customer receivables | 23.22M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 73.14M USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-03-31 | (m) | $156.61M | $189.95M | (m) | $23.22M | $73.14M | (m) |
| 2025-12-31 | (m) | $139.18M | $165.60M | (m) | $15.59M | $54.90M | (m) |
| 2025-09-30 | (m) | $123.59M | $174.86M | (m) | $51.74M | $41.40M | (m) |
| 2025-06-30 | (m) | $117.83M | $192.04M | (m) | $31.91M | $48.18M | (m) |
| 2025-03-31 | (m) | $97.27M | $157.13M | (m) | $40.06M | $22.07M | (m) |
| 2024-12-31 | (m) | $100.62M | $183.58M | (m) | $41.72M | $26.36M | (m) |
| 2024-09-30 | (m) | $95.95M | $97.38M | (m) | $24.89M | $28.68M | (m) |
| 2024-06-30 | (m) | $84.29M | $99.27M | (m) | $20.45M | $34.86M | (m) |
| 2024-03-31 | $235.91M | $64.21M | $141.08M | $78.83M | $15.99M | $27.28M | 3.67× |
| 2023-12-31 | (m) | $63.67M | $107.95M | (m) | $21.27M | $31.12M | (m) |
| 2023-09-30 | $210.12M | $53.47M | $117.83M | $89.25M | $3.04M | $25.58M | 3.93× |
| 2023-06-30 | $225.89M | $47.47M | $112.57M | $88.67M | $24.65M | $23.96M | 4.76× |
| 2023-03-31 | $195.92M | $36.59M | $80.62M | $107.88M | $7.42M | $23.43M | 5.35× |
| 2022-12-31 | (m) | $47.07M | $122.72M | (m) | $12.66M | $21.60M | (m) |
| 2022-09-30 | (m) | $56.49M | $175.76M | (m) | $11.16M | $14.62M | (m) |
| 2022-06-30 | (m) | $43.54M | $94.31M | (m) | $7.81M | $19.92M | (m) |
| 2022-03-31 | (m) | $50.35M | $63.32M | (m) | $29.44M | $13.22M | (m) |
| 2021-12-31 | (m) | $44.82M | $122.47M | (m) | $3.98M | $3.67M | (m) |
| 2021-09-30 | (m) | $34.43M | $190.18M | (m) | $3.22M | $5.61M | (m) |
| 2021-06-30 | (m) | $38.78M | $167.95M | (m) | $2.55M | $6.38M | (m) |
| 2021-03-31 | (m) | $35.45M | $119.86M | (m) | (m) | $2.19M | (m) |
| 2020-12-31 | (m) | $31.85M | $114.04M | (m) | (m) | (m) | (m) |
| 2020-09-30 | (m) | $24.89M | $85.87M | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | $20.55M | $123.46M | (m) | (m) | (m) | (m) |
| 2020-03-31 | (m) | $19.34M | $106.34M | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | $27.83M | $46.93M | (m) | (m) | (m) | (m) |
| 2019-09-30 | (m) | $27.56M | $68.81M | (m) | (m) | (m) | (m) |
| 2019-06-30 | (m) | $30.18M | $82.81M | (m) | (m) | (m) | (m) |
| 2019-03-31 | (m) | $36.89M | $82.63M | (m) | (m) | (m) | (m) |
| 2018-12-31 | (m) | $42.55M | $71.98M | (m) | (m) | (m) | (m) |
| 2018-09-30 | (m) | $28.02M | $69.66M | (m) | (m) | (m) | (m) |
| 2018-06-30 | (m) | $23.14M | $285.52M | (m) | (m) | (m) | (m) |
| 2017-12-31 | (m) | $17.43M | $45.55M | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.